0
CLINICAL NOTES   |    
PRELIMINARY RESULTS WITH FLUPHENAZINE (PROLIXIN) IN CHRONIC PSYCHOTIC PATIENTS
JOHN P. HOLT; ELEANORE R. WRIGHT
Am J Psychiatry 1960;117:157-159.
View Article Information
Embreeville State Hospital, Embreeville, Pa.
text A A A
PDF of the full text article.
Abstract
Fluphenazine is a highly potent psychopharmacologic agent which is effective in controlling behavioral symptoms in chronic psychotic patients with the most pronounced changes manifested in reduced agitation and tension and improved socialization; the drug is also effective in controlling hallucinations and delusions. Through greater individualization of dosage may be required with fluphenazine than with other phenothiazines for maximum benefit with minimum reactions, fluphenazine appears to have great potential usefulness in the treatment of chronic psychotic patients.Abstract Teaser
Figures in this Article

    Your Session has timed out. Please sign back in to continue.
    Sign In Your Session has timed out. Please sign back in to continue.
    Sign In to Access Full Content
     
    Username
    Password
    Sign in via Athens (What is this?)
    Athens is a service for single sign-on which enables access to all of an institution's subscriptions on- or off-site.
    Not a subscriber?

    Subscribe Now/Learn More

    PsychiatryOnline subscription options offer access to the DSM-IV-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

    Need more help? PsychiatryOnline Customer Service may be reached by emailing PsychiatryOnline@psych.org or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

    +
    +
    +

    CME Activity

    There is currently no quiz available for this resource. Please click here to go to the CME page to find another.
    Submit a Comments
    Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
    Comments are moderated and will appear on the site at the discertion of JBJS editorial staff.

    * = Required Field
    (if multiple authors, separate names by comma)
    Example: John Doe



    Related Content
    Articles
    Books
    DSM-IV-TR® Diagnostic and Statistical Manual of Mental Disorders > Chapter 5.  >
    Helping Parents, Youth, and Teachers Understand Medications for Behavioral and Emotional Problems: A Resource Book of Medication Information Handouts, 3rd Edition > Chapter 26.  >
    Dulcan's Textbook of Child and Adolescent Psychiatry > Chapter 49.  >
    Textbook of Psychotherapeutic Treatments > Chapter 24.  >
    What Your Patients Need to Know About Psychiatric Medications, 2nd Edition > Chapter 51.  >
    Topic Collections
    Psychiatric News
    PubMed Articles